Skip to main content
The Globe and Mail
Support Quality Journalism.
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
Just$1.99
per week
for first 24 weeks

Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to globeandmail.com
Just $1.99 per week for the first 24 weeks
Just $1.99 per week for the first 24 weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); } //

Facebook Inc. is moving to stop the spread of anti-vaccine information on its social-media sites by reducing the rankings of groups that spread misinformation, removing an option for advertisers to target people interested in “vaccine controversies” and rejecting ads that promote falsehoods about vaccines.

The company, which made the announcement Thursday, has come under increasing pressure in recent weeks to take action on the barrage of anti-vaccine information found on Facebook and Instagram as cases of vaccine-preventable illnesses rise worldwide. A measles outbreak in B.C. has infected 17 people so far this year. Health officials in Moncton say a whooping-cough outbreak at a high school has infected five people. The World Health Organization has declared vaccine hesitancy as a top global health threat this year.

Many experts say social-media sites are part of the problem, as they allow people to spread false information about vaccines to large audiences. Earlier this week, Ethan Lindenberger, an Ohio teenager who had himself vaccinated despite his mother’s opposition, testified at a U.S. Senate hearing that his mother relied on social-media sites, notably Facebook, as her source for anti-vaccine information.

Story continues below advertisement

Related: Billboards posted by anti-vaccine group in GTA being removed, advertising company says

Tim Caulfield, Canada Research Chair in health law and policy at the University of Alberta, wrote in an e-mail that exposure to anti-vaccine information can contribute to vaccine hesitancy, which is why this decision by Facebook is important.

“Social media, including Facebook, also helps to polarize the discourse. In many ways, social-media platforms are polarization machines. The loud voices win,” he wrote.

Facebook said it will make a series of changes: reduce the ranking of groups and pages that spread anti-vaccine information in the news feed and search functions; remove targeting options that let advertisers promote messages to people interested in “vaccine controversies;” and reject ads that include false information about vaccines. It said it might also disable accounts that continually violate the company’s policies.

Monika Bickert, Facebook’s vice-president of global policy management, wrote in a blog post Thursday that the company is “fully committed to the safety of our community and will continue to expand on this work.”

Facebook, which also owns Instagram, won’t display or recommend content that contains anti-vaccine information on Instagram’s explore function or hashtag pages. Instagram will remove ads that contain vaccine misinformation and will also remove targeting options for ads, such as “vaccine controversies."

The company said it is also looking at introducing other measures, such as ensuring factual information from credible organizations about vaccines appears at the top of search rankings and adding warning language to invitations to join anti-vaccine groups.

Facebook is stopping short of removing anti-vaccine groups and pages because it says it believes that isn’t helpful and that it makes more sense to ensure that people have access to fact-based information to counter anti-vaccine messages.

Your Globe

Build your personal news feed

  1. Follow topics and authors relevant to your reading interests.
  2. Check your Following feed daily, and never miss an article. Access your Following feed from your account menu at the top right corner of every page.

Follow the author of this article:

Follow topics related to this article:

View more suggestions in Following Read more about following topics and authors
Report an error Editorial code of conduct
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

If you do not see your comment posted immediately, it is being reviewed by the moderation team and may appear shortly, generally within an hour.

We aim to have all comments reviewed in a timely manner.

Comments that violate our community guidelines will not be posted.

UPDATED: Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies